SCHEMBL7077367

SCHEMBL7077367

Cc1cccc(C(=O)CC(=O)c2cc(Cc3ccccc3)cc(Cn3ccnn3)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.43
PTGDR2 Q9Y5Y4 2/20 0.38
KLKB1 P03952 1/20 0.35
HTT P42858 2/20 0.35
P2RX7 Q99572 1/20 0.34
BRD4 O60885 2/20 0.34
CYP1A1 P04798 1/20 0.34
ACKR3 P25106 1/20 0.33
ROCK2 O75116 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
KAT7 O95251 1/20 0.32
KAT6B Q8WYB5 1/20 0.32
KAT6A Q92794 1/20 0.32
KAT5 Q92993 1/20 0.32
KAT8 Q9H7Z6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077779 0.89 CYP19A1 (0.46) CYP19A1KLKB1HTTBRD4CYP1A1
SCHEMBL7077565 0.85 CYP19A1 (0.43) CYP19A1PTGDR2KLKB1HTTCYP1A1
SCHEMBL7078206 0.81 CYP19A1 (0.51) CYP19A1HTTCYP1A1
SCHEMBL7595559 0.77 CYP19A1 (0.46) CYP19A1KLKB1HTTCYP1A1
SCHEMBL7084959 0.77 CYP19A1 (0.47) CYP19A1
SCHEMBL7081511 0.72 THRB (0.37) HTTSMN1; SMN2ALDH1A1LMNA
SCHEMBL7083703 0.71 KLKB1 (0.36) CYP19A1KLKB1SMN1; SMN2KAT7KAT6B
SCHEMBL7078148 0.70 CYP19A1 (0.64) CYP19A1
SCHEMBL9284131 0.69 HTT (0.68) CYP19A1HTTCYP1A1SMN1; SMN2ALDH1A1
SCHEMBL7077342 0.69 HDAC1 (0.45) CYP19A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 CYP19A1 180/4885PTGDR2 3092/4885KLKB1 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.